Barclays Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $84
Jefferies Maintains Centene(CNC.US) With Hold Rating, Cuts Target Price to $61
Centene Analyst Ratings
Jefferies Adjusts Price Target on Centene to $61 From $64, Maintains Hold Rating
A Quick Look at Today's Ratings for Centene(CNC.US), With a Forecast Between $65 to $85
Centene's Strategic Growth and Stability Justify Buy Rating Despite Price Target Adjustment
Centene Is Maintained at Overweight by Barclays
Centene Analyst Ratings
Barclays Maintains Overweight on Centene, Lowers Price Target to $84
Oppenheimer Sticks to Its Buy Rating for Centene (CNC)
Analysts Offer Insights on Healthcare Companies: Centene (CNC), CareCloud (CCLD) and Hims & Hers Health (HIMS)
Centene (CNC) Gets a Buy From Barclays
BofA Securities Initiates Centene(CNC.US) With Hold Rating, Announces Target Price $72.5
Barclays Adjusts Price Target on Centene to $84 From $93, Maintains Overweight Rating
Wells Fargo Maintains Centene(CNC.US) With Buy Rating, Maintains Target Price $72
Analysts Conflicted on These Healthcare Names: Centene (CNC), Merck & Company (MRK) and Galapagos (GLPG)
Research Alert: Centene Reports Q1 Earnings, Beats Expectations On Premium Revenue Growth
Wells Fargo Sticks to Its Buy Rating for Centene (CNC)
Centene Price Target Cut to $69.00/Share From $71.00 by Baird
Centene Is Maintained at Neutral by Baird